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Salmonella genomic island 1 (SGI1) contains a multidrug resistance region conferring the ampicillin-
chloramphenicol-streptomycin-sulfamethoxazole-tetracycline resistance phenotype encoded by blaPSE-1, floR,
aadA2, sul1, and tet(G). Its increasing spread via interbacterial transfer and the emergence of new variants are
important public health concerns. We investigated the molecular properties of SGI1-carrying Salmonella
enterica serovars selected from a European strain collection. A total of 38 strains belonging to S. enterica
serovar Agona, S. enterica serovar Albany, S. enterica serovar Derby, S. enterica serovar Kentucky, S. enterica
serovar Newport, S. enterica serovar Paratyphi B dT, and S. enterica serovar Typhimurium, isolated between
2002 and 2006 in eight European countries from humans, animals, and food, were subjected to antimicrobial
susceptibility testing, molecular typing methods (XbaI pulsed-field gel electrophoresis [PFGE], plasmid
analysis, and multilocus variable-number tandem-repeat analysis [MLVA]), as well as detection of resistance
and virulence determinants (PCR/sequencing and DNA microarray analysis). Typing experiments revealed
wide heterogeneity inside the strain collection and even within serovars. PFGE analysis distinguished a total
of 26 different patterns. In contrast, the characterization of the phenotypic and genotypic antimicrobial
resistance revealed serovar-specific features. Apart from the classical SGI1 organization found in 61% of the
strains, seven different variants were identified with antimicrobial resistance properties associated with
SGI1-A (S. Derby), SGI1-C (S. Derby), SGI1-F (S. Albany), SGI1-L (S. Newport), SGI1-K (S. Kentucky),
SGI1-M (S. Typhimurium), and, eventually, a novel variant similar to SGI1-C with additional gentamicin
resistance encoded by aadB. Only minor serovar-specific differences among virulence patterns were detected.
In conclusion, the SGI1 carriers exhibited pathogenetic backgrounds comparable to the ones published for
susceptible isolates. However, because of their multidrug resistance, they may be more relevant in clinical
settings.
Salmonella genomic island 1 (SGI1) is a 43-kb mobilizable
chromosomal region that is located in Salmonella enterica se-
rovars between the genes thdF and yidY or between thdF and
int2 in the retron sequence of S. enterica serovar Typhimurium
(7). In 2008, an SGI1 secondary chromosomal attachment site
for integration of the island between the sodB and purR genes
was described (17). SGI1 contains an antimicrobial resistance
gene cluster (7, 16) located on a 13-kb complex class 1 integron
designated In104 (31), which confers pentaresistance (Penta-R)
to ampicillin (blaPSE-1), chloramphenicol/florfenicol (floR),
streptomycin/spectinomycin (aadA2), sulfamethoxazole (sul1),
and tetracycline [tet(G)] (8). The genes blaPSE-1 and aadA2 are
located on class 1 integrons, named InC and InD, with variable
regions of 1.2 kb and 1.0 kb, respectively (3, 24). The five
resistance determinants are characteristic of the pandemic S.
Typhimurium definite phage type 104 (DT104), which was
globally most predominant in causing infections in humans
since the 1980s (16, 21, 38). SGI1 was first identified in 2000 in
a Canadian multidrug-resistant S. Typhimurium DT104 strain
with the Penta-R phenotype (7). Subsequently SGI1 and sev-
eral variant SGI1 antimicrobial resistance gene clusters were
detected worldwide in different Salmonella serovars and in
Proteus mirabilis (1, 2, 15, 31, 39, 40).
Within the European Union (EU) Network of Excellence
Med-Vet-Net, an investigation on the molecular epidemiology
of SGI1 in enteric bacteria other than S. Typhimurium DT104
was conducted (http://www.medvetnet.org). For this study, a
collection of 445 multidrug-resistant strains (S. enterica, 277;
Escherichia coli, 116; Shigella spp., 43, and Proteus spp., 9),
isolated from animals, food, and humans from eight European
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countries between the years 2002 and 2006, was investigated
(3). By conventional gel-based PCR assays, 53% of the Salmo-
nella isolates were SGI1 positive, showing fragments of both
typical left and right SGI1 junctions (3, 8). Application of
real-time PCR targeting open reading frame (ORF) S004 of
SGI1 detected the island in five additional Salmonella strains.
These strains lacked both SGI1 junctions (one S. enterica se-
rovar Agona and three S. enterica serovar Derby) or showed
the left junction only (one S. Typhimurium) (3).
The spread of multidrug resistance (MDR) among bacterial
populations is alarming, and the detection of SGI1 is regarded
as important for public health (3). Therefore, the character-
ization of SGI1-carrying bacteria as presented in this study is a
useful tool to support efforts in the health care sector. Taking
this into account, we selected from the collection of Amar et al.
(3) all strains that acquired SGI1 and belonged to serovars
other than S. Typhimurium or showed phage types unrelated
to DT104. In order to gain more knowledge on their pheno-
typic and molecular backgrounds, all isolates were analyzed for
their antimicrobial resistance phenotypes and the underlying
molecular mechanisms, screened for selected virulence genes,
and subjected to molecular typing. In this way, a well-charac-
terized collection of strains was set up to be used as controls
for several molecular-epidemiological approaches to antimi-
crobial resistance and virulence.
MATERIALS AND METHODS
Participating institutes. Institutes from eight European countries provided
SGI1-positive Salmonella enterica subsp. enterica isolates for this study:
Agence Nationale de Se´curite´ Sanitaire de L’alimentation de L’environment
et du Travail (ANSES), Maisons-Alfort, France; Central Veterinary Institute
(CVI), Lelystad, The Netherlands; Federal Institute for Risk Assessment
(BfR), Berlin, Germany; Istituto Superiore di Sanita` (ISS), Rome, Italy;
Statens Serum Institute (SSI), Copenhagen, Denmark; Panstwowy Zaklad
Higieny (PZH), Warsaw, Poland; Veterinary Laboratories Agency (VLA),
Weybridge, United Kingdom; and Veterinary Medical Research Institute
(VMRI), Budapest, Hungary.
Bacterial isolates. In a previous work, the Health Protection Agency (HPA),
Laboratory of Enteric Pathogens, United Kingdom, analyzed between May 2006
and March 2007 a European selection of 445 bacterial isolates for the presence
of SGI1. In this study, a total of 152 Salmonella isolates tested positive for SGI1
(3). Of these, 38 strains were sent to the BfR, Berlin, Germany, for further
molecular analyses. This collection of SGI1-positive isolates included (i) all
isolates belonging to serovars other than S. Typhimurium, i.e., S. Agona (1
isolate), S. enterica serovar Kentucky (1), S. enterica serovar Paratyphi B dT
(S. enterica serovar Java) (1), S. enterica serovar Albany (3), S. enterica serovar
Newport (4), and S. Derby (5); (ii) S. Typhimurium non-DT104 (18); and, for
comparison, (iii) S. Typhimurium DT104 (5). The strains were isolated between
2002 and 2006 from humans (19 isolates), animals (10), and food (9) in the eight
European countries (Table 1). We included in this series all isolates (15) that
showed atypical SGI1 properties (lack of SGI1 markers) in the collection de-
scribed by Amar et al. (3). These 15 isolates were designated “unconventional”
in the present study (Table 2).
Phenotypic analysis. Serotyping was done following the White-Kauffmann-Le
Minor scheme (22). Phage typing of S. Typhimurium isolates was performed
according to the method of Anderson et al. (4). All isolates were tested by broth
microdilution, according to the guidelines of the CLSI (11), for their suscepti-
bility to 17 antimicrobial agents: ampicillin (AMP), amoxicillin-clavulanic acid
(AMC), ceftiofur (XNL), chloramphenicol (CHL), ciprofloxacin (CIP), colistin
(COL), florfenicol (FLO), gentamicin (GEN), kanamycin (KAN), nalidixic acid
(NAL), neomycin (NEO), spectinomycin (SPE), streptomycin (STR), sulfameth-
oxazole (SUL), tetracycline (TET), trimethoprim (TMP), and sulfamethoxazole/
trimethoprim (SXT), using custom-defined microtiter plates (Trek Diagnostic
Systems, United Kingdom). The antimicrobial concentrations tested were de-
scribed by Schroeter et al. (37). The breakpoints used are shown in Table 1.
Molecular typing. Plasmid profiling was performed by alkaline denaturation
according to the method of Kado and Liu (28). Vertical electrophoresis was
carried out on 0.8% agarose (standard low melting point; Bio-Rad Laboratories,
Munich, Germany) gels for 3 to 4 h at 100 V. The E. coli reference plasmids R27
(169 kb), R1 (94 kb), RP4 (55 kb), and ColE1 (6 kb) were used as standards for
the determination of plasmid sizes. Genomic DNA from the SGI1 isolates was
subjected to macrorestriction analysis with the XbaI endonuclease (Roche Di-
agnostics, Mannheim, Germany). The generated fragments were separated by
pulsed-field gel electrophoresis (PFGE) using the CHEF-DRIII SYS220/240
system (Bio-Rad Laboratories, Munich, Germany). Agarose plug preparation
and PFGE running conditions followed the PulseNet standardized protocol
(http://www.pulsenet-europe.org). The resulting profiles were analyzed by re-
cording the presence or absence of fragments larger than 33 kb. Profiles with
differences in two or more bands were designated using numbers (e.g., X1, X2,
etc.). Similar patterns in which only one band, or rather, the intensity of a band,
was different were designated using lowercase letters (e.g., X3 and X3a). Mul-
tilocus variable-number tandem-repeat analysis (MLVA) of S. Typhimurium
isolates was performed as described by Lindstedt et al. (32) using an ABI 310
DNA Sequencer (Applied Biosystems, Darmstadt, Germany). MLVA nomen-
clature according to Larsson et al. (29) was used.
Detection of resistance and virulence determinants. In a first approach, de-
tection of resistance and virulence genes in all isolates was undertaken by PCR
amplification (primers and conditions are given in Table SA in the supplemental
material). The isolates were analyzed for the presence of resistance genes related
to their resistance phenotypes. Overall, genes encoding resistance to ampicillin
(blaPSE1, blaTEM1-like, and blaOXA1-like), chloramphenicol (catA1, cmlA, and
floR), gentamicin [aacC2, aacC4, aac(3)-Ie (aacC5), aadB, and armA], kanamy-
cin [aphA1, aphA2, and aac(6)-1b], fluoroquinolones (qnrA, qnrB, and qnrS),
streptomycin (aadA1-like, aadA2, aadA7, and strA-strB), sulfamethoxazole (sul1,
sul2, and sul3), tetracycline [tet(A), tet(B), and tet(G)], and trimethoprim (dfrA1-
like, dfrA5-14, dfrA7-17, dfrA10, dfrA12, and dfrA17) were screened as previously
described (23, 35). The presence of class 1 and 2 integrons was investigated by
using the 5-CS/3-CS and Hep74/Hep51 primers to amplify their variable re-
gions (30, 41). Gene cassettes inserted therein were identified by DNA sequenc-
ing of the amplicons performed by Agowa GmbH (Berlin, Germany). The se-
quences obtained were compared using the BLAST program (http://blast.ncbi
.nlm.nih.gov/Blast.cgi).
For virulotyping analysis, isolates were screened for the presence of 10 viru-
lence genes (avrA, bcfC, gipA, mgtC, ssaQ, sopB, sopC1, sopE1, spvC, and
spi4_D). PCR amplifications were performed as described by Huehn et al. (27).
In a second approach, nine isolates (4 S. Typhimurium, 1 S. Newport, 1 S.
Paratyphi B dT, 1 S. Albany, 1 S. Kentucky, and 1 S. Derby), representing
different serovars, phage types, countries, and/or origins, were selected for an
extensive analysis of the presence of virulence determinants using DNA microar-
rays (see Fig. 2). Probes, microarray production, and performance of whole-
genome DNA labeling, hybridization, analysis, and validation were as previously
described (26). Virulence determinants for each strain analyzed (101 genes) were
categorized according to their locations on the Salmonella genome: SPIs, pro-
phages, plasmids, islets, and fimbrial clusters. Signals that were assigned as
“uncertain” (cutoff between 0.25 and 0.4) by microarray analysis were verified by
PCR as described previously (26), and an individual decision was made for the
presence or absence of each target.
Additional analysis of unconventional isolates lacking a classical chromo-
somal attachment site. Mapping of the regions flanking the primary chromo-
somal integration site of SGI1 was performed for a selected group of five isolates
already described as unconventional by Amar et al. (3): S. Agona 08-02864
(MDR region and S004 present; other markers outside the MDR region and left
and right junctions absent); S. Derby 08-02866, 08-02867, and 08-02868 (only
S004 present); and S. Typhimurium 08-02865 (right junction absent). For this,
PCR amplifications were carried out targeting genes framing the SGI1 region:
upstream (dnaN, dnaA, rpmH, rnpA, yidC, and thdF) and downstream (int2, urt,
rt, yidY, yidZ, yieE, yieF, yieG, and yieH). The primers for the genes cited above
were designed from the sequence of S. Typhimurium LT2 (accession number
AE008879) (see Table SA in the supplemental material).
To detect a secondary integration site of SGI1, previously reported in the
intergenic region between the chromosomal genes sodB and purR, primers
sodB-F and purR-B were used (17). Only in case of a nonintegration of SGI1 was
an amplicon size of 508 bp expected.
Data analysis. Results were analyzed with BioNumerics software (version 5.1;
Applied Maths, Sint-Martens-Latem, Belgium).
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RESULTS
Molecular typing. In 33 of the 38 isolates (87%), one to five
plasmids were detected, ranging from approximately6 to 180
kb. All S. Typhimurium isolates (n  23) carried a serovar-
specific virulence plasmid of 94 kb (33, 36). No plasmids were
identified in five isolates belonging to the serovars S. Newport
(3 isolates), S. Kentucky (1), and S. Derby (1).
PFGE analysis using XbaI generated 26 patterns. The 23 S.
Typhimurium isolates showed 14 different patterns, the 5 S.
Derby isolates 4 patterns, the 4 S. Newport isolates 3 patterns,
and the 3 S. Albany isolates 2 different patterns (Fig. 1).
By MLVA analysis, the 23 S. Typhimurium isolates were
assigned to 21 MLVA types (Table 1). Two of the types (allele
numbers 3-13-8-24-311 and 3-11-5-NA-311) were represented
by two strains each, isolated in Germany and Hungary. All
isolates showed identical alleles for loci STTR-9 and -3. The
highest numbers of alleles were found in loci STTR-6 (12
variants) and STTR-10 (13 variants).
Phenotypic and genotypic characterization of antimicrobial
resistance. Fourteen different resistance patterns, conferring
resistance to at least four antimicrobial substances, were iden-
tified among the isolates tested (Tables 1 and 2). The SGI1
characteristic Penta-R phenotype was detected in 29 isolates
throughout all serotypes. Variations within this phenotype
were observed in several isolates (Tables 1 and 2).
The prevalence of resistance genes and their distributions
in the different Salmonella serovars are shown in Table 2.
Twenty-five isolates were positive for the five characteristic
SGI1 resistance genes, blaPSE-1, floR, aadA2, sul1, and tet(G),
but again, variations were found (Table 2). The sul1 gene was
present in all 38 isolates. The plasmid-mediated-quinolone-
resistance (PMQR) gene, qnrB19, was detected on a 2.7-kb
ColE-like plasmid in a Dutch S. Typhimurium isolate (CIP
MIC  0.5 g/ml; NAL MIC  8 g/ml) of human origin (25).
All isolates tested in this study harbored class 1 integrons
(Table 2), whereas none carried class 2 integrons. Based on the
gene cassette content of the variable region and the amplicon
size, the nine different types of class 1 integrons shown in Table
3 were observed. The two class 1 integrons typically linked to
the presence of SGI1, generating PCR amplicons of 1,200 bp
and 1,000 bp and carrying the blaPSE-1 and aadA2 gene cas-
settes, respectively, were present in 25 (66%) of the isolates.
Two S. Typhimurium isolates carried 3-CS-defective integrons
that could not be detected using the 5-CS/3-CS primers but
were identified by linking the integrase gene intI1 and the
different gene cassettes. One isolate carried the aadA2 and
blaPSE-1 variable regions characteristic of the SGI1 integron,
together with an additional defective integron with the dfrA12-
aadA2-cmlA1-aadA1 variable region (5), while the aadB vari-
able region and a defective integron containing aadA2 were
present in the other (Tables 2 and 3).
Due to the differences in the SGI1 MDR gene content, the
S. Albany (three isolates), S. Kentucky (1), S. Newport (4), and
S. Typhimurium (2) isolates were considered part of the un-
conventional isolates (Table 2).
Analyses of SGI1 flanking regions on unconventional iso-
lates lacking a classical chromosomal attachment site. In the
other five unconventional isolates, one S. Agona (08-02864),
three S. Derby (08-02866, 08-02867, and 08-02868), and one S.
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Typhimurium (08-02865), one or both junctions were absent.
The flanking regions of these isolates were analyzed by PCR
screening. In all five isolates, the normal SGI1 attachment sites
thdF and yidY, as well as all analyzed up- and downstream
flanking genes (dnaN, dnaA, rpmH, rnpA, yidC, thdF, int2, urt,
rt, yidY, yidZ, yieE, yieF, yieG, and yieH), were present.
Integration of SGI1 into a secondary chromosomal attach-
ment site between the genes sodB and purR was not observed,
because in all isolates, a PCR product of 518 bp was generated.
Virulotyping. All isolates were screened by PCR analysis for
the presence or absence of 10 selected virulence genes. The
ssaQ, mgtC, spi4_D, sopB (carried by Salmonella pathogenicity
islands [SPIs]), and bcfC (fimbria-related) genes were present
in all the isolates tested. Except for the S. Paratyphi B dT
strain, all isolates also carried the avrA gene located in SPI1.
The spvC gene, carried by the Salmonella virulence plasmid,
was present in all S. Typhimurium isolates except two. Like-
wise, the sodC1 gene, located on a bacteriophage, was found in
all isolates belonging to S. Typhimurium, S. Newport, and S.
Paratyphi B dT, whereas for sopE1, only the four S. Newport
and three S. Derby isolates tested positive. The gipA gene was
detected in only one S. Typhimurium isolate. Altogether, in
this strain collection, seven different combinations of virulence
genes were detected (Table 2).
Since major serovar-specific differences were observed, nine
representative Salmonella isolates were analyzed by DNA mi-
croarray in more detail. All four S. Typhimurium isolates
tested had identical virulence gene repertoires (Fig. 2). In
contrast to the five isolates of other serovars tested, all S.
Typhimurium isolates possessed gogB (encoding a leucine-rich-
repeat protein), usually located on Gifsy-1, but lacked gipA
(encoding a Peyer’s patch-specific virulence factor, GipA).
Virulence markers associated with the prophage Gifsy-2
were always present in S. Typhimurium, but no markers of
the Gifsy-3 and Fels-1 prophages tested positive. Other pro-
phage genes, like hldD_DT104 (encoding a DT104-specific
phage protein) and irsA (encoding a putative transcriptional
regulator and internal response element to stress) were
present, but sopE1 (encoding a translocated effector pro-
tein) was absent. The Salmonella virulence plasmid genes
rck, spvC, and spvR were positive, and with the exception of
cdtB (encoding a cytolethal distending toxin), fhuA_Spa (en-
coding an outer membrane protein receptor), htrE (encod-
ing a probable porin/fimbrial assembly protein), and stkC
FIG. 1. XbaI PFGE profiles (X) of representative isolates. To define the profiles, only bands at 33 kb were considered. Similar profiles with
only a one-band difference are designated by letters. Profiles with differences in two or more bands are designated by numbers. Lanes M contained
XbaI-digested DNA of S. enterica serovar Braenderup H9812, which was used as a size standard. T, S. Typhimurium; Ag, S. Agona; Al, S. Albany;
D, S. Derby; J, S. Paratyphi B dT (S. Java); K, S. Kentucky; N, S. Newport.
TABLE 3. Class 1 integrons detected in SGI1-positive isolates (n  38)
Variable-region size(s)a (bp) Gene cassette(s)a n Serovar(s)
1,000  1,200 aadA2  blaPSE-1 23 S. Typhimurium (19), S. Derby
(2), S. Agona, S. Paratyphi
B dT
1,000  1,200  1,600 aadA2  blaPSE-1  dfrA1-aadA1 1 S. Typhimurium
1,000  1,200  defective integronb aadA2  blaPSE-1  dfrA12-aadA2-cmlA-aadA1
b 1 S. Typhimurium
1,200  1,250 blaPSE-1  dfrA1-orf 3 S. Albany
1,000 aadA2 3 S. Derby
1,600 aac(3)-Ie-aadA7 1 S. Kentucky
1,600  1,200  750 aac(3)-Ie-aadA7  blaPSE-1  dfrA15 4 S. Newport
1,200  800 blaPSE-1  aadB 1 S. Typhimurium
800  defective integronc aadB  aadA2c 1 S. Typhimurium
a PCR/sequencing was performed using the 5CS/3CS primers (30).
b Defective integron, undetectable by 5CS/3CS primers, as described by Antunes et al. (5).
c Defective integron, undetectable by 5CS/3CS primers. PCR products were observed using the following primer sets: 5CS/aadA2-B, int1-R/aadA2-R, and
int1-R/qacE-R.
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(encoding an outer membrane usher protein), all genes an-
alyzed on virulence islets were present. For the fimbria-
coding genes tested, pefA (encoding a virulence plasmid
fimbrial protein) was positive and steB (encoding an outer
membrane fimbrial usher protein) was negative, in contrast
to the isolates of other serovars.
The S. Paratyphi B dT isolate was solely negative for avrA
(encoding a protein that inhibits activation of NF-	B),
hldD_DT104, and the fimbrial stjB (encoding a putative fimbrial
usher protein), and it had none of the Gifsy-1 genes tested. For
the islet genes, the only difference from S. Typhimurium was
fhuA_Spa instead of fhuA_STM.
S. Albany was characterized by a truncated SPI-3 missing
rhuM (encoding a putative cytoplasmic protein) and possessed
only sseI of Gifsy-2 and hldD_DT104 of the other prophage
genes. In contrast to S. Typhimurium and S. Paratyphi B dT,
no pagK (encoding a PhoPQ-activated protein) was detected,
but stkC was present. Also, lpfD (encoding a long polar fimbrial
operon protein), pefA, and stcC (encoding a putative outer
membrane protein) of the fimbrial genes were missing.
For S. Kentucky, five genes were found to be different from
those of S. Albany, namely, the islet gene msgA (encoding an
ssrB-regulated factor) and fimA (encoding a major type 1 sub-
unit fimbrin) were negative, while lpfD and tcfA (encoding an
S. Typhi colonization factor and putative fimbrial protein)
were positive. The Gifsy-2 gene sseI was negative only for this
isolate.
The S. Derby strain analyzed had the same fimbrial set as S.
Albany. In addition, the isolate was positive for irsA and solely
for htrE. The genes msgA and pagK were negative.
Also, one S. Newport strain was investigated for its virulence
genes. Probes were negative for sseK1 (encoding Salmonella-
secreted effector K1) of SPI-2 and rhuM of SPI-3. Of the
Gifsy-2 genes, gtgA was missing, but genes of other prophages
were positive in the case of hldD_DT104 and, only in this
isolate, sopE1. Additionally, it possessed no srfJ gene (encod-
ing a putative virulence factor activated by transcription factor
SsrB), which was found only for this isolate.
DISCUSSION
The acquisition of genomic islands has played a central role
in bacterial evolution as a mechanism of diversification and
adaptation (10). Since the emergence of pandemic multidrug-
resistant S. Typhimurium DT104, its antimicrobial resistance-
conferring genomic island, SGI1, has increasingly attracted
research interest. In particular, the horizontal-transfer poten-
tial of SGI1 has been intensively studied (8, 16). In this study,
we sought to investigate the molecular properties of SGI1-
carrying epidemic Salmonella isolates in a European strain
collection of human, animal, and food origin. We specially
focused on isolates that belonged to serovars other than S.
Typhimurium or to phage types of S. Typhimurium other than
FIG. 2. Virulence determinant microarray data for 9 SGI1-positive
Salmonella strains. The analyzed genes are grouped according to their
genomic locations (SPI-1 to SPI-7; prophages Gifsy-1, Gifsy-2, Gifsy-3,
and Fels-1; plasmids; and islets) or function (fimbrial).
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DT104. We intended to establish the relationship between
virulence, multidrug resistance, and the presence of SGI1.
The results of typing showed wide variability within the se-
ries (38 isolates from seven serovars). PFGE analysis distin-
guished within the same serovar several XbaI patterns, with a
total of 26 different patterns. MLVA analysis of the S. Typhi-
murium isolates was also very heterogeneous (21 types). These
findings are in line with the supposed epidemiological nonre-
latedness of the strains, which were isolated in different coun-
tries and from different sources. In contrast, characterization
of the phenotypic and genotypic antimicrobial resistance in
general displayed certain serovar-specific features. Apart from
the resistance genes organized in SGI1, several strains exhib-
ited additional resistance genes with either chromosomal or
plasmidic locations. Altogether, we could identify eight possi-
ble SGI1 variants in our strain collection, based on the partic-
ular resistance genotype and the presence of class 1 integrons.
The majority of strains (61%; 23 isolates), belonging to the S.
enterica serovars Agona (1 isolate), Paratyphi B dT (1), and
Typhimurium (21), harbored the classical SGI1 resistance
genes (Fig. 3) (3, 34). Isolates with a gene repertoire typical of
the variants SGI1-A and SGI1-C (Fig. 3) were found only
within S. Derby (one each). The three S. Albany strains har-
bored genes suggesting the presence of SGI1-F (Fig. 3) (14).
SGI1-L was recognized in the four S. Newport isolates and
SGI1-K1 in S. Kentucky (Fig. 3), as previously described (13,
18). In the S. Typhimurium isolate 08-02886, the resistance
gene cluster found (Fig. 3) suggests the presence of the variant
SGI1-M, which was first described for a Dutch S. Typhimurium
DT104 horse isolate by Vo et al. (39). To our knowledge, this
is the first time that an SGI1-M variant has been detected in a
German S. Typhimurium DT120 isolate of rodent origin. The
same variant was also detected by Rodríguez et al. (35) in
German S. Typhimurium isolates (phage types DT104L and
DT012) of equine, cat, and avian origin associated with the
presence of the extended-spectrum beta-lactamase-encoding
gene blaCTX-M-1 . An integron with a variable region of 800 bp
containing the aadB gene cassette was also found in another S.
Typhimurium isolate, 08-02885, which additionally carried a
3-CS-defective integron with an aadA2 gene cassette. We as-
FIG. 3. SGI1 variants corresponding to the resistance gene repertoire found within the isolates (S. Agona and S. Paratyphi B dT, SGI1; S.
Typhimurium, SGI1 and SGI1-M; S. Derby, SGI1-A and SGI1-C; S. Albany, SGI1-F; S. Newport, SGI1-L; S. Kentucky, SGI1-K1). The scheme
is based on information from Amar et al. (3), Boyd et al. (9), Cloeckaert et al. (13), Doublet et al. (18), and Vo et al. (39). Only antimicrobial
resistance genes are shown. , not present in all isolates.
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sume that this isolate contains a novel variant similar to
SGI1-C (34) with additional acquired resistance to gentamicin,
but this assumption needs further investigation. The SGI1 has
historically been linked to S. Typhimurium, and we have dem-
onstrated that, despite the clonal diversity of the S. Typhimu-
rium isolates (shown by PFGE and MLVA analyses), there is
low genetic variation in the genomic island, since among 23
isolates, 21 carry the classical SGI1, 1 the SGI1-M variant, and
another, as mentioned above, a potential new variant.
The virulotyping results for strains carrying SGI1 indicated
that only little or no variation was found for most genes incor-
porated in SPIs and for the fimbrial marker. Thus, the genes
ssaQ , mgtC , spi4_D , sopB , and bcfC were present throughout
all serovars in all 38 isolates. It was observed that some viru-
lence patterns were serovar specific, e.g., all S. Newport and
most S. Typhimurium strains shared a common virulotype,
which was characterized in both by the presence of eight genes.
The association of a certain serovar with a virulence-associated
gene panel was also confirmed by the microarray results in this
study and a previous study conducted by Huehn et al. (27)
within the Med-Vet-Net project on a wide collection (77 iso-
lates, 10 of them SGI positive) of European Salmonella isolates
belonging to different serovars. The presence of genes in the
SGI1 that can play a role in the virulence of the carrier isolates
has been mentioned previously (6, 20). The data presented
here and by Huehn et al. (27) show that, despite minor differ-
ences, SGI1-positive isolates carry more or less identical viru-
lence gene repertoires. Mapping of the unconventional isolates
did not reveal any aberrations either in the SGI1 integration
sites (8) or in the flanking regions. Nevertheless, in some iso-
lates, the left and right junctions (1 S . Agona and 3 S . Derby
isolates) or only the right junction (one S. Typhimurium iso-
late) could not be detected by conventional PCR, although the
presence of SGI1 was proved by real-time PCR targeting S004
in the precursor study carried out by Amar et al. (3). For the
S. Typhimurium isolate in which only the left junction was
detectable, one might assume genetic rearrangements or sin-
gle-nucleotide polymorphisms (SNPs) at the ends of SGI1. For
the S . Derby and the S . Agona isolates, we proved SGI1 was
not integrated in a secondary chromosomal attachment site
between the genes sodB and purR , as suggested by Doublet et
al. (17). To elucidate the exact genetic organization of this
region, further mapping and sequencing experiments will be
undertaken.
In summary, we set up a panel of strains from different
origins that can be used as a reference collection for molecular
studies. We could observe great phenotypic and genetic hetero-
geneity of SGI1-positive isolates. Apart from the resistance
genes typical of SGI1 [blaPSE-1, floR, sul1, tet(G), and aadA2],
other chromosomal or plasmid-located resistance determi-
nants were detected. As shown by other authors (9, 10, 13–18,
34, 39), several genetic events led to a large number of SGI1
variants, which can be spread through vertical and horizontal
transfer. Due to their virulence gene repertoires and their
resistance properties, some of these variants/isolates may be-
come clinically relevant. The data presented provide a solid
basis for cooperation in resistance and virulence studies lead-
ing to a scientifically based risk characterization.
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